IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. [electronic resource]
Producer: 20150812Description: 1476-85.e7 p. digitalISSN:- 1097-6825
- Adult
- Animals
- Antibodies, Monoclonal -- pharmacology
- Case-Control Studies
- Cell Adhesion Molecules -- genetics
- Chronic Disease
- Disease Models, Animal
- Eosinophil Cationic Protein -- genetics
- Eosinophils -- drug effects
- Female
- GATA3 Transcription Factor -- genetics
- Gene Expression -- drug effects
- Humans
- Interleukin-17 -- antagonists & inhibitors
- Male
- Mice
- Middle Aged
- Nasal Polyps -- complications
- Neutrophils -- drug effects
- Nuclear Receptor Subfamily 1, Group F, Member 3 -- genetics
- Receptors, Interleukin-17 -- genetics
- Rhinitis -- complications
- Sinusitis -- complications
- T-Box Domain Proteins -- genetics
- Transforming Growth Factor beta1 -- genetics
- Transforming Growth Factor beta2 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.